LYKA LABS
Back to Cashflow Statement
|
LYKA LABS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹1.90 Cr | ₹1.77 Cr | ₹8.95 Cr | ₹79 Cr | ₹8.81 Cr |
What is the latest Cash Flow from Operating Activities ratio of LYKA LABS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹1.90 Cr |
| Mar2024 | ₹1.77 Cr |
| Mar2023 | ₹8.95 Cr |
| Mar2022 | ₹79 Cr |
| Mar2021 | ₹8.81 Cr |
How is Cash Flow from Operating Activities of LYKA LABS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1.90 Cr | 7.11 | |
| Mar2024 | ₹1.77 Cr | -80.20 | |
| Mar2023 | ₹8.95 Cr | -88.70 | |
| Mar2022 | ₹79 Cr | 799.30 | |
| Mar2021 | ₹8.81 Cr | - | |
Compare Cash Flow from Operating Activities of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹269.5 Cr | -3% | -0.9% | -54.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹392,147.0 Cr | -2.1% | -7.7% | -9.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,208.0 Cr | -2.6% | -6.8% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,190.0 Cr | 0.1% | 5.5% | 25.3% | Stock Analytics | |
| CIPLA | ₹110,790.0 Cr | -1.9% | -9.3% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,587.0 Cr | 3.5% | -5.2% | -11.8% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | -3% |
-0.9% |
-54.3% |
| SENSEX | -1.3% |
-3.1% |
6.8% |
You may also like the below Video Courses